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Abstract
Signal Fusion and Semantic Similarity Evaluation for Social Media
Based Adverse Drug Event Detection
Hameeduddin Irfan Khaja
Recent advancements in pharmacovigilance tasks have shown the usage of social media
as a resource to obtain real-time signals for drug surveillance. Researchers demonstrated a good
potential for the detection of Adverse Drug Events (ADEs) using social media much earlier than
the traditional reporting systems maintained by official regulatory authorities like the United
States Food and Drug Administration (FDA). Existing automated drug surveillance systems have
used various types of social media channels and search query logs for monitoring ADE signals.
In this thesis, we address two key performance issues related to automated drug
surveillance systems. The first is to improve the ADE signal detection by analyzing signals from
multiple social media channels, and the second is usage of semantic similarity to evaluate ADE
narratives detected by drug surveillance systems. Most current approaches for detecting ADEs
from social media rely on a single channel: forums or microblogs or query logs. In this study we
propose a new methodology to fuse signals from different social media channels. We use
graphical causal models to discover potentially hidden connections between data channels, and
then use such associations to generate signals for ADEs. Further, prior work have not emphasized
much on the language of healthcare consumers, which is often casual and informal in expressing
health issues on social media. There is a high potential to miss the semantic similarity between
ADE terms extracted from social media and terms from formal official narratives when the two
sets of terms do not share exact text. Thus, we exhibit the usage of semantic similarity to enhance
accuracy of detected ADEs, and evaluated similarity measurement algorithms developed over
biomedical vocabularies in ADE surveillance domain. We experimented on a dataset of drugs
which had FDA black box warnings with a retrospective analysis spanning years 2008 to 2015.
The results show a better detection rate and an improved performance in terms of precision,
recall and timeliness using our proposed methods.
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Chapter 1
Introduction
1.1 Problem and Motivation
According to the United States Federal Drug Administration (FDA), an Adverse Drug Event
(ADE) is defined as any sign or symptom or disease which is unintended and harmful and happens
for the normal dosage of the drug [1]. The two main approaches to discover ADEs are
premarketing review and postmarketing surveillance. The premarketing review is carried out
before the drug is released into the market to detect any potential adverse events. In
premarketing review potential risks are identified and they are communicated to the prescribers.
Unfortunately, the premarketing review process does not completely identify or address all
possible adverse events due to the shortcoming of duration and size, thus mostly insufficient of
detecting all adverse events caused by the drug [2]. Postmarketing surveillance is carried out by
pharmacovigilance teams for reporting ADEs after the drug has been released into the market.
High morbidity and mortality rates are associated with adverse drug events, and hence,
pharmacovigilance serves a critical task in postmarketing surveillance [3], [4]. Existing traditional
approach of reporting adverse events in postmarketing surveillance includes a centralized
voluntary reporting system like U.S. FDA Adverse Event Reporting System (FAERS) [5], the Yellow
Cards from the UK Medicines Agency (MHRA) [6], and VigiBase – the World Health Organization’s
(WHO’s) ADE reporting system [7], [8]. Researchers have been working on finding and improving
novel approaches for pharmacovigilance tasks besides the traditional approach by focusing on
capturing real-time health data through healthcare content over Web 2.0 [9], [10]. Over the past
decade many studies have used publicly available information sources: Web forums, chat rooms,
blogs, social networking sites, news websites, personal webpages, and so on to detect ADEs [3].
Recent advancements in pharmacovigilance tasks have shown that the usage of social
media data as a good resource to obtain real-time signals for drug surveillance [8]–[13].
Researchers have shown a good potential for the detection of ADEs using social media much
earlier than the traditional reporting systems [8], [14]. In this thesis, we address two key
performance issues related to automated drug surveillance systems, the first is to improve the
ADE signal detection by analyzing signals from multiple social media channels, and the second is
usage of semantic similarity to evaluate ADE narratives detected by drug surveillance systems
against official narratives, such as those from the FDA.
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Most automated drug surveillance systems detecting adverse events from social media
or Web 2.0 relied on single channels [3]. One exception is Adjeroh et al., which proposed that
fusing heterogeneous signals from social media channels could generate good detection rate for
adverse drug events [8]. Their results were quite promising as the signal fusion system they
developed utilizing Twitter and search query log signals could detect drug alerts much earlier
than the FDA. In this study we propose a new methodology to fuse signals from three different
social media channels: Twitter, discussion forums and FDA Adverse Event Reporting System
(FAERS) based on a causality model for ADE surveillance. Many studies have exhibited the
usefulness of causality models in solving similar identification problems in economics [15]. We
used graphical causal models to discover potentially hidden connections between data channels
and use such associations to generate signals for adverse drug events.
Also, we note that most of the work have not emphasized the issue of language usage. It
is well-known that the language healthcare consumers use in expressing health issues on social
media forums and microblogging websites like Twitter is often very casual and informal [16]. On
the other hand, warning labels and notifications from official regulatory agencies (such as the
FDA in the US) are formal documents and usually described in a language that is very carefully
selected by biomedical experts. This raises a major concern as the words detected from social
media channels by the surveillance systems do not exactly match with the contents of a typical
FDA Black Box Warning (BBW) label or alert notification.
For many pairs of terms, there is a potential to miss the semantic similarity between social
media extracted ADE terms and terms from FDA notification when two sets of terms do not share
exact text. More specifically, the problem is as follows: given a formal FDA ADE narrative: X= {x 1,
x2, … xn}, and an informal ADE narrative from social media Y= {y1, y2, … ym}, determine the
semantic similarity between X and Y. The three major issues related to semantic similarity in
automated drug surveillance are: 1) How to measure semantic similarity between social media
narratives and official formal documents, 2) How to use semantic similarity to evaluate the
accuracy of detected ADEs, and 3) How to use semantic similarity to improve ADE signal
detection. This work focuses on the first two problems. In general, X and Y could represent any
two documents with words from a given language. Thus, semantic similarity can have
applications in other fields such as general healthcare, automobile industry, medical devices,
ecommerce, etc.
Previously, Yang et al. [11] attempted to address the problem of health consumers’
language over the Internet by generating adverse drug reaction (ADR) lexicons using Consumer
Health Vocabulary (CHV) – developed by Zeng et al. [16]. However, this did not address the issue
comprehensively, as there are over 200 biomedical vocabularies in just UMLS (Unified Medical
Language System), which also includes CHV [17]. Here, we use UMLS-Similarity program
developed by McInnes et al. [18], for computing semantic similarity. It incorporates well-known
2

semantic similarity and semantic relatedness measures. The prominent ones include path finding
measures (such as Rada et al. [19], and Wu & Palmer [20]) as well as information content (IC)
measures (such as Jiang and Conrath [21], and Sánchez et al. [22]). In prior work, Park et al.
evaluated vocabularies from UMLS based on diabetes-related terms extracted from social media
[23]. However, it confines itself to only one subset of the vast healthcare domain. In this work we
focused on evaluating all the measures listed in UMLS-Similarity and vocabularies in UMLS to
determine the best combination of measures and vocabulary in computing semantic similarity
for evaluating adverse drug event narratives.

1.2 Thesis Contributions
The contributions of the thesis are summarized as follows:

•
•
•
•

A detailed study conducted on automated drug surveillance systems developed
for detecting adverse drug events from social media.
Proposed a causality-based signal fusion scheme to generate adverse drug event
signals from potentially hidden connections between social media channels.
Proposed methodology to use semantic similarity for evaluating the performance
of automated drug surveillance systems against the gold standard FDA alerts.
The results reported in this thesis have crucial implications for various stakeholder
groups, including regulatory agencies like FDA, health institutes, postmarketing
monitoring teams, pharmaceutical companies and consumer advocacy groups.

1.3 Thesis Outline
Chapter 2 presents a brief background and prior work related to this thesis. It is organized
in two parts. The first section discusses existing automated methods for adverse drug events
surveillance using social media, and the characteristics of various social media channels based on
the CRUFS methodology presented by Abbasi and Adjeroh [9]. The second section describes
measures of semantic similarity developed over biomedical vocabularies, an overview of
biomedical vocabularies in the UMLS Metathesaurus, and related work which demonstrated the
use of semantic similarity in biomedical domain.
In Chapter 3 we propose a novel methodology of signal fusion based on causality. Here,
we introduce the dataset we used to generate signals followed by the methodology that explains
the graphical causal model for signal fusion. We also describe the experiment setup to implement
3

our strategy, and finally a discussion on the results we obtained in comparison with prior work.
In Chapter 4 we present our evaluation of semantic similarity measures and biomedical
vocabularies for comparing the ADE narratives. We discuss various aspects of selecting and
refining biomedical vocabularies to be used with similarity measures, and finally evaluating their
combinations against human ratings to get the best vocabulary and measure configuration for
our ADE surveillance problem domain. Lastly, concluding remarks and future directions are
offered in Chapter 5.

1.4 Publication Resulting in part from this Thesis
H. I. Khaja, M. Abate, W. Zheng, A. Abbasi, and D. Adjeroh, “Evaluating Semantic Similarity
for Adverse Drug Event Narratives,” in Proceedings - 2018 International Conference on Social
Computing, Behavioral-Cultural Modeling & Prediction and Behavior Representation in Modeling
and Simulation (SBP-BRiMS) 2018. [Accepted]
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Chapter 2
Background and Related Work
The traditional systems for ADE reporting includes MedWatch from U.S. FDA Adverse Event
Reporting System [5], the Yellow Cards from the UK Medicines Agency (MHRA) [6], and the
VigiBase – the World Health Organization’s (WHO’s) ADE reporting system [7]. Each of these
system work in a very similar fashion, that includes visiting their official website and reporting
the ADE in detail by filling ADE reporting forms. The ADEs submitted to MedWatch becomes part
of world’s largest ADE database, FDA’s Adverse Event Reporting System (FAERS). This database
includes 6.2 million ADE records and around 400,000 records are added each year. However, only
20,000 reports are submitted voluntarily by providers and patients each year. This varying extent
of voluntary reporting is because of the lengthy, formal process which requires filling of an
extensively detailed ADE reporting form which is time consuming and difficult [24]. Above all,
FDA generally requires up to 44 months to detect an ADE associated with a drug [25], whereas,
automated drug surveillance systems were able to successfully detect many ADEs at least 15
months earlier (with some detected 2 to 3 years beforehand) [9].

2.1 Automated Adverse Drug Event Surveillance Systems
Karimi et al. in their survey on postmarketing drug surveillance classified prior works into
two main categories. The first class of methods uses social media resources to identify ADR
mentions. The second delve into detection of adverse events using signal detection techniques,
with the aim of reporting ADEs earlier than FDA [26].
It has been observed that existing automated postmarketing drug surveillance systems
have used various social media channels including forums like: DailyStrength [13], MedHelp [11],
PatientsLikeMe [14] etc., search query logs from major search engines like Google, Bing, or
Yahoo!, [14], [26], the advancement of Twitter as a superior micro-blogging website, many
studies have demonstrated it as a good channel for monitoring drug signals [3], [8], [13], [14].
These channels exhibit different characteristics with respect to Credibility, Recency, Frequency,
and Salience, an evaluation proposed by Abbasi and Adjeroh [9]. Social media channels such as
Twitter and certain health forums have lower credibility as they are prone to spam. On the other
hand, forums exhibit greater salience as they are capable of containing greater background and
covering more context than a 140-character tweet, and far more relative to a query
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encompassing a few search terms [9], despite having lower volume of content than Twitter and
search queries.
ADE signal detection from social media resources incorporates methodologies which are
good enough to detect potential adverse events earlier than the gold standard FDA’s MedWatch.
Precision, Recall and detection time has been the prominent evaluating factors for such ADE
surveillance systems. Abbasi et al. [14] in their study discuss that most of the ADE signal detection
approaches use “mention models” that build ADR occurrence frequency time-series at different
temporal granularities (e.g., weekly, monthly, yearly), and apply temporal association rules or zscore thresholds to the time series [14].
Many works in automated ADE surveillance have relied on evaluating individual social
media source channels: forum or microblogs or search query logs, rather a combination of these
channels to evaluate adverse drug events detection. When applied to a large dataset, these
methods have very low detection rates. In a prior work, Adjeroh et al. demonstrated correlationbased peak labeling fusion scheme on Twitter and search query logs [8]. They showed that fusing
these social media channels together could generate good detection rate for adverse events.
Nevertheless, as is well known, correlation does not necessarily imply causation, neither is
correlation necessary for causation [27]–[29]. We address this issue by applying causality models
to fuse channel-wise time series data. Our causality problem using time series from drug-ADR
references is different from traditional causality analysis: rather than the usual long-range time
series [28], we focus on causality over local temporal windows.
Another important aspect of this work is to determine the accuracy of suggested adverse
drug events with respect to the reference ADE narrative for which we use semantic similarity.
Additionally, semantic similarity can also be used to improve the strength of ADE signals from
social media channels such as microblogs, chat rooms, web forums, social networks, and so on.

2.2 Semantic Similarity Measures for Biomedical Vocabularies
Semantic similarity is defined as a relatedness measure between two terms in a taxonomy
having an IS-A relationship [19]. Semantic relatedness defines functional relationships, such as PARTOF, TREATS, AFFECTED BY, and other functional relations in addition to IS-A relation. Semantic similarity
measures are mainly classified into knowledge-based measures and distributional-based
measures [30]. Knowledge-based semantic similarity measures are taxonomy-based measures.
Typical examples include random walk, path finding, and information content (IC) measures [30].
Path finding based semantic similarity measures use the distance between two concepts in a
taxonomy tree as the main objective of computing semantic similarity. A drawback of path
6

finding based measures is that they give equal weight to all relationships between concepts. This
limitation is addressed by Information content (IC) based measures by allocating different
weights to different relationships based on the information content of concepts [30]. Information
content is a measure of concept specificity. Intrinsic IC measures compute information content
(IC) of concepts from the taxonomic structure itself. The idea of intrinsic IC is based on the
assumption that the taxonomic structure of vocabulary is organized in a comprehensive way,
where concepts with many children and few parents have lower IC value than the concepts which
are more specific or have less children. Random walk measures on the other hand simulate walks
on a concept graph and define the relatedness on overall connectivity between concepts unlike
the shortest path in path finding based and IC-based measures.
Distributional-based measures deploy a domain corpus in addition to the taxonomic
structure of the vocabulary [31]. A study by Pedersen et al. proposed a distributional-based
measure called context vector measure for semantic relatedness and showed that this measure
outperformed knowledge-based path finding measures [31]. Sánchez et al. showed that
knowledge-based intrinsic IC measures outperformed distributional measures [32]. Garla and
Brandt [30] observed that these studies have methodological differences preventing a direct
comparison. However, they showed that for a wide range of vocabularies and benchmarks,
intrinsic IC measures performed as well or better than distributional measures. In addition, they
suggested the use of UMLS vocabularies for higher concordance with human judgments. Yet, no
ADE specific evaluation has been done. Moreover, the performance of similarity measures
heavily depends on vocabulary chosen.

2.3 Biomedical Vocabularies in the UMLS Metathesaurus
The UMLS, or Unified Medical Language System, is a set of files and software that brings
together many health and biomedical vocabularies and standards to enable interoperability
between computer systems [17]. The Metathesaurus is the biggest component of the UMLS. It is
a large biomedical thesaurus that is organized by concept, or meaning, and it links similar names
for the same concept from over 200 different source vocabularies. These vocabularies are
electronic versions of various thesauri, classifications, code sets, and lists of controlled terms
used in patient care, health services billing, public health statistics, indexing and cataloging
biomedical literature, and/or basic, clinical, and health services research [33]. Some of the
prominent source vocabularies in UMLS Metathesaurus includes: ICD-10-CM (International
Classification of Diseases, Tenth Revision, Clinical Modification), LOINC (Logical Observation
Identifiers Names and Codes), MSH (Medical Subject Headings), RxNorm, and SNOMED CT
(Systemized Nomenclature of Medicine Clinical Term).
7

In UMLS Metathesaurus, source vocabularies are represented by the acronym SAB
(Source Abbreviation) and are organized based on concepts described by Concept Unique
Identifier (CUI). CUI is the basic and most general representation of a concept or terminology
wherein each CUI has its own definition/meaning, and the possible relations (REL) to other
concepts are defined based on CUIs. Refer Table B.1 in Appendix B, for the list of all relationships
defined in UMLS [33].
Several studies have earlier evaluated semantic similarity measures. These measures
have been evaluated based on a specific standard rating coded by healthcare professionals as
seen in Pedersen et al. [31] and Sánchez et al. [32], where pairs were coded by physicians and
experts. In addition to this very few biomedical ontologies have been addressed in testing the
semantic measures. Most efforts on this issue relied only on SNOMED CT or MSH considering
these vocabularies as gold standard [30]–[32], while ignoring other biomedical vocabularies.
Pesquita et al. [34] addressed some aspects of selection of semantic similarity measures,
but the work is limited to Gene Ontologies and its specific applications. In our work, we consider
the use of semantic similarity measures in general biomedical applications, especially where the
terms are extracted from social media healthcare resources and other microblogging websites.
For a social media generated signal, we have the language as a major concern and hence
the testing on selection of semantic similarity measure and source vocabulary should be based
on ratings obtained from general healthcare consumers, in addition to ratings from healthcare
professionals. Thus, we used human ratings as the standard to compare the performance of each
combination of measure and vocabulary configuration. The human ratings obtained for this
evaluation consists of ratings from people who use social media as a primary source for healthrelated information as well as ratings from people who are working in healthcare industry.
Our methodology involves comparison of similarity values for every combination of
semantic similarity measures and selected vocabulary configurations with human ratings as a
benchmark to select the best combination as discussed in Chapter 4. Therefore, the objective of
this work is to have a best combination of the vocabularies from UMLS Metathesaurus and the
semantic similarity algorithms to compare the narratives in the reference document (E.g. FDA
black box warnings), and the target narrative identified by the automated drug surveillance
system using social media.
In this thesis, we first demonstrate signal fusion using causality model to detect Adverse
Drug Events and report the detection rate using this methodology. In addition to this, we evaluate
the suggested ADE narrative against FDA’s black box warnings to measure the efficiency of the
system using biomedical semantic similarity measures. We evaluate the efficiency in terms of
precision, recall and timeliness as discussed in Chapter 3.
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Chapter 3
Causality Based Signal Fusion for ADE Detection
In this chapter, we propose a new methodology to fuse signals from three different social
media user-generated content (UGC) channels: Twitter, Discussion Forums and FDA Adverse
Event Reporting System (FAERS) based on a causality model for ADE surveillance. For causality
modeling, we used graphical causal models to represent causal relations, and then used the
Granger causality test to detect potential flags for ADE. This chapter is organized as follows:
Section 3.1 introduces the dataset and signals we utilized for our work. Section 3.2 describes the
causality model in detail including the Granger Causality tests, ADE signal detection and
evaluation of detected ADE narratives against official FDA documents. Section 3.3 discusses the
experimental setup for selecting possible candidates from the signals and filtering them to obtain
the potential flag for ADEs. Finally, Section 3.4 provides a discussion of our experimental results
and compares it with the correlation-based signal fusion methodology described in [8].

3.1 Dataset and Signals
The methodology to generate signals has been adapted from Adjeroh et al. [8], where the
authors described the signal generation process as simple drug-ADR reference model, based on
a predefined list of keywords for human anatomy, drug reactions, and drug administration
problems. That is, for a given data source, we consider joint references to a given drug (or its
various aliases) and a keyword from each of the three keyword sets. We recorded the number of
such references in terms of weeks from 2008 to 2014, and then formed a time series by
normalizing these counts into empirical probabilities and z-scores.
To identify potential ADR mentions, lexicons were developed for anatomy-related terms,
reactions, and drug administration keywords. The lexicons, which were developed by research
assistants with backgrounds in biology and medicine, were used to tag the tweets. For example,
the statement “I’ve been through headaches since I started taking Actos.” would be tagged as
“I’ve been through <ANATOMY><REACTION> since I started taking <DRUG>”. For word-sense
disambiguation, we used the CMU part-of-speech tagger designed specifically for tweets [35], to
help improve the likelihood that anatomy and side-effect tags were applied appropriately.
For an adverse event E, given a time window ti ∈ T = {t1 ... tg}, where tg is the current time
period of the analysis, and tg is less than the eventual event time period te. Let D(d) represent the
9

number of drug names associated with event E that appear in document d. Let C = {d 1 ... dn}
signify the set of documents occurring during ti within a given channel, where each D(dj) ≥ 1.
Further, let A(dj), R(dj), and M(dj) represent the number of anatomy, reaction, and administration
terms present in dj, respectively. The total raw score for time ti is then computed as:
𝑛

𝑠(𝑡𝑖 ) = ∑(𝐷(𝑑𝑗 ) + 𝐴(𝑑𝑗 ) + 𝑅(𝑑𝑗 ) + 𝑀(𝑑𝑗 ))

(1)

𝑗=1

Each s(ti) is converted to a z-score z(ti) = (s(ti) – μg)/σg , where μg and σg are the mean and
standard deviation, respectively, across all ti in T plus the training period where s(ti) > 0. T can
vary and depending on the resolution of the signals—such as daily, weekly, and monthly time
models, as well as the value of the current window time period tg.
We computed the signals for a total of 90 Drugs which had an FDA black box warning for
ADEs between 2008 and 2015. Data from three user-generated content channels was collected:
twitter, forums, and FDA Adverse Event Reporting System (FAERS). Approximately 12 million
tweets containing drug-name keywords spanning 2008 to 2014 were gathered through Topsy’s
API. Over 5 million postings from 10 popular health forums were obtained using web crawlers.
The forums include: AskAPatient, CafePharma, DailyStrength, DrugBuyersGuide, Drugs.com,
Drugs-Forum, eHealth, MedHelp, MedsChat, and PatientsLikeMe. The postings spanned the time
period 2008 onwards. In addition to the social media signals, we used FAERS data obtained for
the selected drugs for the years 2008 to 2014 and processed them as signals using the above
approach.

3.2 Causality Based Signal Fusion
For causality modeling, we used graphical causal models [15], [29], [36]–[38] to represent
causal relations, and then used the Granger causality test [28], [39]–[42] to detect potential
causal relations. Causality between two variables, say A and B is determined by checking their
relationship with a third variable, say C, in particular their informational (in)dependence with C.
For example, Graph (19) in Figure 3.1 (each rectangle contains equivalent structures. Figure
adapted from [15]). An arrow indicates dependence between nodes. Thus, A and B are
independent, while A and C have a dependence relationship. An overall network of causal
relations in a large system can then be constructed by combining triples such as (A, B, C). Three
key assumptions for graphical causal models are causal sufficiency, Markov condition, and
stability [12]. In particular, the Markov condition states that the probability of a node can be
written by conditioning on the node’s parent. Thus, given the network: A→B→C←D, the joint
distribution can be written as: P (A, B, C, D) = P(A).P(D).P(B|A).P(C|B, D). Since C has two parents
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B and D, both are involved in its representation. By computing all the possible joint probabilities
for a given network triple, Kwon and Bessler [15] identified 11 possible classes of observationally
equivalent causal structures for a given network triple. Figure 3.1 shows these classes for
variables A, B and C. Each block denotes an equivalent class. For example, from Bayes theorem,
we see that for Graph (12) (A→C→B), P (A, B, C) = P(A).P(C|A).P(B/C) = P(A).
([P(A|C).P(C)]/P(A)).P(B|C) = P(A|C).P(C).P(B|C). Similarly, for Graph (13) (A←C→B), P (A, B, C) =
P(C).P(A|C).P(B|C). Their joint probabilities are same; thus the two graphs are equivalent.

Figure 3.1: Equivalent classes in graphical causal model. (From [15])

3.2.1 Granger Causality Test
Engle and Granger [28] developed a method to check whether a given time series, say X(t)
is caused by another time series, say Y(t), even when X and Y are not correlated. Here, Y(t) is said
to be caused by X(t) if a series of t-tests and F-tests on lagged values of X and of Y, show that the
statistically significant information about future values of Y are provided by the X values (see
Figure 3.2). Basically, Y(t) causes X(t) if the future values of X(t) can be predicted more accurately
using the lagged values of both Y(t) and X(t) than using only lagged values of X(t). In this work,
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we model dependence based on Granger-causality. That is, A Granger-causes B (A→B) implies
that B depends on A.

Figure 3.2: Causality between two time-series variables (X and Y).

3.2.2 Causality Based ADE Detection
From Figure 3.1, we observe three interesting classes in Graph (7) (C→A←B), Graph (11)
(A→C←B), and Graph (15) (A→B←C) (see Figure 3.3). These structures are unique -- they contain
unconnected colliders or v-structures. Their joint probabilities cannot be factored into other
representations [15]. These three classes identify causation among the given set of variables.

Figure 3.3: Causal v-structures.

Our problem is thus to search over the space of the causal directed acyclic graphs to
identify these causal v-structures for our problem of ADRs. By specifying how the variables A, B,
and C relate to our channels Forums, FAERS and Twitter, we convert our problem of signal
detection to that of finding causal v-structures. Here, the nodes (variables) will correspond to
12

Forums, FAERS and Twitter, signals for each drug. We propose the following steps: (1) Map A, B,
and C (network node triples) appropriately to our channels for each drug; (2) Identify pairwise
dependencies (cointegration or causation) between variables using the Granger model based on
a defined threshold for F-value (𝜏𝑓 ) and p-value (𝜏𝑝 ) for the F-tests; (3) Analyze results to
determine causal v-structures. Each local region where a causal v-structure is detected becomes
a candidate for an ADE. For each drug, we compute the candidates for the three v-structures.
The potential flags are identified as the candidates occurring in at least one v-structure.
For a given drug, the month with the highest number of flags denotes the detection of
ADE as alert signal. The time specified by the alert signal will be considered as the detection time
for ADE. We search the anatomy and reaction terms based on the detection time of the flag
across all the three channels: Twitter, Forums and FAERS, and accumulate unique terms for both
anatomy and reaction categories. We then match the obtained anatomy and reaction terms for
the ADE against the anatomy and reaction terms given in FDA’s black box warning for the drug
to evaluate precision and recall of the detected ADE terms. For computing precision and recall,
we apply semantic similarity algorithms from the biomedical domain (discussed in chapter 4).

3.3 Experiment Setup
We obtained signals as described in Section 3.1 for a total of 335 weeks ranging from
2007-12-30 to 2014-05-25 from three channels: Forums, FAERS, and Twitter for the list of 90
drugs shown in Table A.1 in Appendix A. Of the 90 drugs there were 16 drugs which had multiple
black box warnings on different dates and hence we analyzed them for each of the dates.
For each drug, we compute the Granger causality across the permutation of pairs formed
by the 3 channels using the grangercausalitytests program from statsmodels package in Python
[43]. We specify the input parameter maximum lag as 3 and we design our Granger test for
multiple window sizes (∆ = 8, 10, 12, 14, and 16 weeks). Graphically, our Granger model for
testing causality between any two social media channels (say Forums(A) and Twitter(C)) can be
depicted in Figure 3.4. Our causality testing for ADE surveillance is different from traditional
causality analysis which usually focuses on long-range time series [28]. The figure explains that
we test Granger causality over local temporal windows defined by the window size ∆. The whole
experiment is performed for both overlapping as well as non-overlapping windows for the 335week dataset.
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Figure 3.4: Implementation of Granger causality tests over local temporal windows.

3.3.1 Selecting Candidates for V-Structures
We now analyze the Granger test results for the pairs of channels by forming the vstructures for each window size separately. We defined our threshold for Granger results: 𝜏𝑓 as
2.5 and 𝜏𝑝 as 0.15 a slightly moderate one to get more combination of flags. The set of candidate
windows in v-structure (say A→C←B) are added from both Granger tests, A→C and B→C. For
each window having any lag satisfying thresholds (𝜏𝑓 , 𝜏𝑝 ) in Granger test A→C, we select the
corresponding nearest window from B→C which satisfies (𝜏𝑓 , 𝜏𝑝 ), as candidates in A→C←B.
Likewise, for each window having any lag satisfying thresholds (𝜏𝑓 , 𝜏𝑝 ) in Granger test B→C, we
select the corresponding nearest window from A→C satisfying (𝜏𝑓 , 𝜏𝑝 ), (see Figure 3.5).

Figure 3.5: Forming candidates in causal v-structure (A→C←B).
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To automate this process, we developed the procedure for candidate selection as shown
in Figure 3.6 for choosing the candidate set of v-structures.
Procedure for Selecting Candidates in V-Structures
Algorithm FormStructure(A→C, B→C):
1: Consider v-structure A→C←B (say A represents Forum, B represents FAERS, and C
represents Twitter) and ∆ be the window size (for overlapping windows ∆ =1).
2: Scan the results of A → C satisfying thresholds to get candidates, A_candidates
3: D = SelectCandidates(A_candidates, B→C)
4: Scan the results of B → C satisfying thresholds to get candidates, B_candidates
5: D1 = SelectCandidates(B_candidates, A→C)
6: Merge D & D1, store complete candidate set for A→C←B for window size ∆.
Algorithm SelectCandidates(A→C, B→C):
1: Initialize set D.
2: for each row A_ID in A_candidates:
// to find corresponding row in B → C, A_corres
3:
set B_ID = A_ID
4:
for B_IDArray = [B_ID – 2∆, B_ID – ∆, B_ID, B_ID + ∆, B_ID + 2∆]
5:
rowID=B_IDArray[2]
6:
if rowID has a candidate:
7:
A_corres = rowID
8:
break
9:
rowID1= B_IDArray[1], rowID2= B_IDArray[3]
10:
if rowID1 or rowID2 has a candidate:
11:
if rowID1 has a candidate, A_corres = rowID1
12:
else A_corres = rowID2
13:
break
14:
rowID1= B_IDArray[0], rowID2= B_IDArray[4]
15:
if rowID1 or rowID2 has a candidate:
16:
if rowID1 has a candidate, A_corres = rowID1
17:
else A_corres = rowID2
18:
break
19:
A_corres = B_ID
// if none of the neighbors is found
20:
end if
21:
end for
22:
merge A_candidates and A_corres, add to D.
23: end for
24: return D
Figure 3.6: Candidate selection algorithm.
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Figure 3.7 shows the graphical representation of the candidate selection process for the
v-structure A→C←B. As shown in figure we have n windows for Granger test results for A→C and
B→C, here n varies on the number of weeks and also the window size ∆. For each window (say x)
having any lag satisfying thresholds (𝜏𝑓 , 𝜏𝑝 ) in A→C we find the corresponding window in B→C
such that any lag in the window y=x or its closest neighboring windows (y-2∆, y-∆, y+∆, y+2∆)
satisfies the thresholds (𝜏𝑓 , 𝜏𝑝 ). The process is repeated for windows in B→C, and we form such
(x,y) candidates from A→C and B→C for the v-structure A→C←B.

Figure 3.7: Candidate selection for A→C←B.
Using this procedure, we compute candidate sets for all the window sizes (∆ = 8, 10, 12,
14, 16 weeks), for the v-structures: A→C←B, A→B←C, and B→A←C.

3.3.2 Finding Potential Flags
We now report the potential flags for each drug representing a potential ADE. One can
clearly observe that the procedure used to select candidates for forming the v-structures as
discussed in Section 3.3.1 is not strict, as any window having a single lag satisfying the threshold
(𝜏𝑓 , 𝜏𝑝 ) is considered to be a candidate. Thus, there is a need to filter the candidates before
processing them for finding potential flags. In theory, it is desired to have all lags satisfying the
threshold for a selected candidate, but this would be too strict and could miss some candidates.
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In practice, we made the filtering process flexible by varying threshold (𝜏𝑓 , 𝜏𝑝 ) and defining rules
based on the number of lags satisfying a given threshold (𝜏𝑓 , 𝜏𝑝 ). Given a v-structure A→C←B,
we define rules Rule(α, β) as follows: For a selected candidate in A→C←B, at least α number of
lags should satisfy (𝜏𝑓 , 𝜏𝑝 ) on Granger test A→C and at least β number of lags should satisfy
(𝜏𝑓 , 𝜏𝑝 ) on Granger test B→C, and vice versa. We choose rules:
1.
2.
3.
4.

Rule(1,1),
Rule(2,1),
Rule(2,2), and
Rule(3,1).

where each rule would indicate the number of lags that satisfies (𝜏𝑓 , 𝜏𝑝 ) for Granger
tests of a candidate in v-structure.
Figure 3.8 shows an example for Rule(2,1). Here the Rule(2,1) for v-structure A→C←B,
would only select candidates satisfying thresholds for at least 2 lags on Granger test A→C and at
least 1 lag on Granger test B→C, and at least 1 lag on A→C and at least 2 lags on B→C.

Figure 3.8: Filtering candidate selection for A→C←B using Rule(2,1).
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Empirically we decided two thresholds:
1. 𝜏𝑓 =2.5 with 𝜏𝑝 =0.15 for all the 4 lag rules, and
2. 𝜏𝑓 =3.0 with 𝜏𝑝 =0.05 only for Rule(1,1) and Rule(2,1).
With the above threshold and lag rule combination we have 6 separate settings to filter
candidate sets from v-structures:
1.
2.
3.
4.
5.
6.

𝜏𝑓 =2.5 with 𝜏𝑝 =0.15 for Rule(1,1),
𝜏𝑓 =2.5 with 𝜏𝑝 =0.15 for Rule(2,2),
𝜏𝑓 =2.5 with 𝜏𝑝 =0.15 for Rule(2,1),
𝜏𝑓 =2.5 with 𝜏𝑝 =0.15 for Rule(3,1),
𝜏𝑓 =3 with 𝜏𝑝 =0.05 for Rule(1,1), and
𝜏𝑓 =3 with 𝜏𝑝 =0.05 for Rule(2,1).

For each drug we set the target date as 3 months before FDA’s black box warning date.
The evaluation of potential flags for each setting is based on the filtered candidate set for vstructures, such that the selected candidate for a flag should be present in at least two vstructures and at least one signal in it should end before the target date.

Figure 3.9: Finding potential flags from v-structures.
For a given flag if both the signals in it ends before the target date then we consider it as
red flag otherwise it is considered to be a yellow flag. We follow the procedure shown in Figure
3.10 in filtering the candidate set and evaluating potential flags.
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Procedure for finding Flags from Candidate Set
Algorithm FindFlags(A→C←B, A→B←C, B→A←C):
1: Consider setting (τf , τp ) as threshold with lag rule Rule(n1 , n2 ) and ∆ as window size.
Take the target, as 3 months before FDA’s black box warning date. Initialize list D1.
2: d1=FilterCandidates(A→C←B, τf , τp , n1 , n2 , ∆)
3: d2=FilterCandidates(A→B←C, τf , τp , n1 , n2 , ∆)
4: d3=FilterCandidates(B→A←C, τf , τp , n1 , n2 , ∆)
5: s=MultipleOccurrence(d1, d2, d3)
6: flags=SearchFlags(d1, d2, d3, s)
7: <red_flags, yellow_flags> = RedYellow(flags, target)
Algorithm FilterCandidates(X, τf , τp , n1 , n2 , ∆):
1: Let A_ID, A_f1, A_p1, A_f2, A_p2, A_f3, A_p3 denote attributes for left-hand side of X. Let
B_ID, B_f1, B_p1, B_f2, B_p2, B_f3, B_p3 denote attributes for right-hand side of X.
2: Initialize D as empty dataframe.
3: for candidate rows, C in X:
4:
Initialize count1 = 0, count2 = 0.
5:
for i=1 to 3:
6:
if A_fi >= τf and A_pi <= τp , increment count1, end if
7:
if B_fi >= τf and B_pi <= τp , increment count2, end if
8:
end for
9:
if (count1 >=n1 and count2 >=n2 ) or (count1 >=n2 and count2 >=n1 ) add C to
dataframe D, end if
// D is filtered candidate set for v-structure X.
10: end for
11: return D.
Algorithm MultipleOccurrence(d1, d2, d3):
1: Initialize s as empty set
// Finding potential flags.
2: for dataframe, X in [d1, d2, d3]:
3:
initialize s1 as empty set
4:
for candidate row, C in X:
// to add unique signals from the v-structure X
5:
if A_ID is not in s1, append A_ID to s1, end if
6:
if B_ID is not in s1, append B_ID to s1, end if
7:
end for
8:
append s1 to s.
9: end for
10: for j in s:
11:
if count(j) < 2, remove j from s, end if
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// candidates from multiple v-structures
12: end for
13: return s
Algorithm SearchFlags(d1, d2, d3, s):
1: Initialize K as empty dataframe.
2: for each dataframe X, in [d1, d2, d3]:
3:
for candidate row, C in X:
4:
if A_ID in s, append C to K, end if
5:
if B_ID in s and A_ID not in s, append C to K, end if
6:
end for
7: end for
8: return K
Algorithm RedYellow(flags, target):
1: for each row, C in flags:
2:
if A_endDate < target and B_endDate < target, append C to red_flags.
3:
else if A_endDate < target or B_endDate < target, append C to yellow_flags.
4:
end if
5: end for
6: return <red_flags, yellow_flags>
Figure 3.10: Algorithm for finding potential flags.
Following the above algorithm, we computed red and yellow flags for the combinations
of window sizes 10, 12, 14 and 16 weeks with the 6 rule settings defined above.

3.3.3 Evaluating ADE Narratives
Now that we obtained potential flags for all drugs using different settings and window
configurations, we compute the month which has the highest number of potential red flags to be
considered as the time for the alert signal for the drug. We also specify that in the absence of red
flags, we consider the month which has the highest number of yellow flags as the alert signal.
The complete methodology is summarized in Figure 3.11.
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Figure 3.11: Methodology for causality-based signal fusion.
Based on the alert signal month for each drug, we extract anatomy and reaction terms
from all the 3 channels: Twitter, Forums and FAERS. The extracted anatomy and reaction terms
are again processed to remove redundancy. Finally, we use Semantic Similarity measure sanchez
with CHV-SNOMEDCT vocabulary configuration (refer Chapter 4) for evaluating our social mediabased ADE narratives against the official FDA documents. The performance is evaluated in terms
of detection rate, precision and recall for both overlapping windows and non-overlapping
windows setup.
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3.4 Experiment Results and Discussion
3.4.1 Experiment Results
As mentioned in the methodology section, we evaluated our approach using overlapping
as well as non-overlapping window configurations for the time series data of the 90 drugs having
a total of 107 FDA black box warnings. Table 3.1 and Table 3.2 represent a detailed result for
detecting red and yellow flags for the complete dataset.
Table 3.1: Detection using non-overlapping windows.
Setting
(𝝉𝒇 , 𝝉𝒑 )

Rule

Total BBW
Detected

(2.5, 0.15)
(2.5, 0.15)
(2.5, 0.15)
(2.5, 0.15)
(3.0, 0.05)
(3.0, 0.05)

(1, 1)
(2, 1)
(2, 2)
(3, 1)
(1, 1)
(2, 1)

65
54
20
23
37
15

Detected as Red

Detected as Yellow

Maximum
Flags for a Drug

55
47
18
19
31
12

10
7
2
4
6
3

96
41
8
12
15
5

Table 3.2: Detection using overlapping windows.
Setting
(𝝉𝒇 , 𝝉𝒑 )

Rule

Total BBW
Detected

(2.5, 0.15)
(2.5, 0.15)
(2.5, 0.15)
(2.5, 0.15)
(3.0, 0.05)
(3.0, 0.05)

(1, 1)
(2, 1)
(2, 2)
(3, 1)
(1, 1)
(2, 1)

62
52
20
32
46
14

Detected as Red

Detected as Yellow

Maximum Flags
for a Drug

62
52
20
32
45
14

0
0
0
0
1
0

661
203
17
36
60
24

For each configuration we computed the month which has the highest number of
potential red flags of all the settings as alert signal for the drug. We also specify that in the
absence of red flags, we consider the month which has the highest number of yellow flags as the
alert signal. Thus, for each drug we obtain alert signal. We evaluate the performance of the
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system in terms of Precision and Recall using the semantic similarity techniques. We evaluated
our results for the drugs dataset discussed in Section 3.1. Table 3.3 shows these results
summarized in terms of mean and median statistics over all the drugs for both overlapping and
non-overlapping window configurations. Here we present the performance factors in terms of
detection rate: the proportion of drugs identified as having a potential Adverse Drug Event. We
also evaluate the suggested ADE narrative against the gold standard FDA black box warnings by
computing the precision and recall for anatomy and reaction terms.
Table 3.3: Performance statistics for causality configurations.
Anatomy
Reaction
Window
Detection
Statistic
Configuration
Rate
Precision
Recall
Precision
Recall
Mean
0.1883
0.5637
0.1778
0.5339
Overlapping
0.62
Median
0.1667
0.6667
0.1667
0.5000
NonOverlapping

0.63

Mean
Median

0.1972
0.1434

0.4524
0.3765

0.1755
0.1429

0.4649
0.5500

Timeliness or detection time is another perspective to evaluate an automated drug
surveillance system. Detection rate tells us whether the considered approach is able to detect
the adverse drug event or not, however one would also like to see how early the adverse drug
events gets detected; so that it helps the concerned authorities like FDA to respond. Thus, we
computed the detection time for each black box warning in terms of number of months prior to
the FDA. Figure 3.12 shows the list of drugs detected with their earliest detection time prior to
the FDA’s black box warning for overlapping as well as non-overlapping windows.
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Figure 3.12: Detection time for drugs.
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3.4.2 Comparison with Prior Work
We have also compared our results against the correlation-based peak labeling fusion
scheme for search engine query log terms and Twitter data used by Adjeroh et al. [8]. One key
observation here is that Adjeroh et al. [8] used the dataset which had only 46 drugs experimented
for FDA alerts. On the other hand, the drug dataset for this work is based on FDA blackbox
warnings (BBWs) for a total of 90 different drugs. Furthermore, 16 drugs had more than one black
box warning (the drug Aceon, had three black box warnings) making it a total of 107, which is
more than double the size of dataset used in [8]. Thus, a direct comparison of all the performance
factors cannot be done; however, the detection rate and the timeliness of detection provide a
fair measure to compare how well the ADEs have been detected. Figure 3.13 and Table 3.4 show
the comparison in terms of detection rate. (first 5 rows are described in [8]).

Table 3.4: Comparing detection rate for fusion techniques.
Fusion Technique
Detection Rate
0.6522
fuse([Q, T], [52,104])
0.5435
fuse([Q, T], [n,52,104])
0.3478
fuse[Q, T], [n])
0.4783
fuse([Q], [n])
0.3261
fuse([T], [n])
0.6222
Causality-based (overlapping)
0.6333
Causality-based (non-overlapping)
0.6777
Causality-combined
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Figure 3.13: Detection rate comparison.

The detection rate for both overlapping and non-overlapping configurations performed
well better than 4 of the fusion techniques proposed by Adjeroh et al. [8]. Also, we achieved a
detection rate of 68 percent when we take into account the total detections from both
overlapping as well as non-overlapping configurations which is more than the highest detection
rate: 65 percent described in [8].
We represent the timeliness in terms of maximum, mean and median statistic of
detection time before FDA action for overlapping as well as non-overlapping window
configurations; and then compare against the prior work [8] (see Table 3.5).

Table 3.5: Timeliness comparison.
Detection time before FDA action (in months)
Fusion Technique
Mean
Median
Maximum
Causality-based (overlapping)
19.75
14.99
55.07
Causality-based (non-overlapping)
19.46
14.00
56.02
fuse([Q, T], [52,104]) [8]
23.58
23.5
36

For both the causality-based window configurations we get almost the same result in
terms of detection time. Our causality-based fusion techniques had significantly good maximum
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detection time in comparison with prior work. However, prior work’s detection time for mean
statistic was slightly better than our results, whereas the median statistic shows more difference
in the timeliness of causality-based fusion techniques against the correlation-based fusion
scheme described in [8].
As mentioned earlier, we used three different user-generated content (UGC) channels in
this study for 107 blackbox FDA warnings. On the other hand, prior work used only Twitter and
search query logs for the 46 FDA alerts drug dataset [8]. Thus, considering the dataset and the
social media channels being used, our comparative analysis tells us that, the causality-based
technique discussed in this work has relatively better performance.

3.4.3 Discussion
Clearly, we can see that Non-overlapping window configuration has slightly better
detection rate when compared to overlapping window configuration (see Table 3.3). This could
be due to the fact that the non-overlapping window covers a greater range of weeks for
candidates in a v-structure allowing it to get a longer cross channel detection, thus having more
potential candidates for drug signals. On the other hand, the overlapping window has a focused
and shorter range of weeks for a given flag. This observation also answers the point that
overlapping configuration has relatively greater precision and recall values than non-overlapping
configuration, as the focused signals are the ones that have a high signal strength for a flag.
From Table 3.2, it is evident that no yellow flags are detected for overlapping
configuration except for the setting: (𝜏𝑓 = 3.0, 𝜏𝑝 = 0.05) with Rule(1,1), essentially forming the
flags for shorter range and having more red flags than non-overlapping window configuration.
Additionally, the maximum number of flags detected for any drug is far more than nonoverlapping window configuration for all settings. This observation could indicate that
overlapping configuration is better capable of capturing more number of closer hidden
connections between channels, but one needs to be cautious with the false alarms. A false alarm
is defined as the potential flag representing an ADE falsely, i.e. an alert signal which does not
correspond to the FDA action for a drug. Differentiating false alarms and improving the social
media alert signal for the drugs could be an interesting future aspect to the study.
In this work, we propose causality-based methodology to identify ADEs from the
associations between social media UGC channels. Identifying the false alarms and detecting ADEs
for unknown FDA blackbox warnings could be some of the directions for the future work.
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Chapter 4
Evaluating Semantic Similarity for ADE Narratives
In this chapter, we discuss a new approach to evaluate semantic similarity measures in
biomedical domain for comparing ADE narratives. Our objective is to evaluate all the possible
similarity measurement algorithms (SMAs) listed in UMLS-Similarity program along with the
vocabulary configurations (VCs) from UMLS Metathesaurus database to determine the best
combination of measures and respective vocabulary configurations in computing semantic
similarity in the domain of adverse drug event surveillance. This chapter is organized as follows:
Section 4.1 introduces the materials and methods focusing on the dataset we used and the
methodology involved in this work. Section 4.2 describes the experiment and results in detail
including the experimental setup, results computed in each phase, and finally results showing
evaluation of ADE narratives. The last Section 4.3 presents a brief discussion on our methodology
in the light of the results we obtained.

4.1 Materials and Methods
Our methodology follows the procedure: 1) Identify the best vocabulary configurations
(VCs) to use, 2) Determine the best combination of VCs and similarity measurement algorithms
(SMAs) via joint optimization, and 3) Perform semantic similarity measurement using VC and SMA
on narratives from social media against FDA narratives.

4.1.1 Datasets
Problem Domain Terms: In order to evaluate vocabulary configurations and similarity
measures, we used anatomy and reaction terms extracted from social media channels for the 90
drugs described in Chapter 3. The dataset was formed after the extracted terms were processed
for removing redundancy. The dataset had 105 initial anatomy terms and 202 initial reaction
terms (referred as clusters), which was expanded with words with similar meanings, resulting in
a new list with 178 anatomy terms, and 417 reaction terms. Refer Appendix B for the list of
problem domain terms and clusters.
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Human Ratings: Language is a major concern in evaluating the signals generated from
social media, hence, the testing on SMAs and VCs should be based on the ratings obtained from
general healthcare consumers along with healthcare professionals. Thus, we used human ratings
as the standard to compare the performance of each combination of SMA and VC. Initially, we
had 178 anatomy terms and 417 reaction terms, and forming pairs with all these terms would
lead to over 100,000 pairs and that would have been impossible for the respondents to rate the
similarity. Thus, we randomly selected 30 anatomy terms forming a set of 435 [(30*29)/2]
anatomy pairs and 40 reaction pairs forming a set of 780 [(40*39)/2] reaction pairs. Further, to
rate these 1215 pairs we contacted 6 computer science graduate researchers having appreciable
knowledge of biomedical vocabulary usage over social media. Finally, based on their ratings a
template with a set of 100 pairs was designed comprising 50 anatomy pairs and 50 reaction pairs.
This template had rating options 0, 0.25, 0.5, 0.75 and 1 indicating levels from non-similar to very
similar. We obtained 130 user ratings across the United States. This consists of 54 individuals
coming from 5 different universities with health sciences and engineering background, and 76
from Amazon Mechanical Turk users having at least US Bachelor’s degree. Further, we selected
117 ratings by excluding the outliers that had a negative correlation with the mean. We also
analyzed the inter-rater agreement in terms of average correlation between raters. We filtered
the ratings to achieve the benchmark of 80% average correlation and this resulted in a total of
107 ratings.
FDA BBW: To evaluate our work, we used FDA black box warning (BBW) labels as gold
standard references and extracted ADE terms from the labels. We used FDA BBW data from
January 2008 to April 2015 (http://www.fda.gov/safety/medwatch/safetyinformation/). This
included 107 BBWs, on 90 drugs over the seven-year period.

4.1.2 Selection of Vocabulary Configurations (VCs)
Since the biomedical terms are found in multiple vocabularies it becomes a challenging
question to decide which vocabulary to be used. The harder part is to find how good a given
vocabulary is, in terms of covering all terms in a given problem domain.
Initial Selection: As stated earlier, UMLS has a huge collection of biomedical vocabularies
which serves as a good resource for our work. However, we cannot use all the vocabularies in
UMLS-Similarity due to performance and computational issues (see [44] for example). For our
domain-specific social media extracted ADE terms, we followed the discussions in Park et. al [23],
and selected vocabularies represented by source abbreviation (SAB): SNOMEDCT_US, CHV, MSH,
LCH_NW, LNC, RXNORM, NCI_FDA, VANDF, and MTHSPL from UMLS [33]. We note that the work
in [23] was based on terms extracted from social media using queries for terms related to
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diabetes which is one of the most common groups of diseases and with a high degree of comorbidity. For a more comprehensive treatment, we have considered some additional
vocabularies where the content is closely related to ADE terms; namely, FMA, MDR, UWDA,
WHO, NCI_NICHD, NCI_CTCAE, NDFRT_FDASPL, ICD10CM, MTHHH, and GS. Thus, given our
specific problem domain of analyzing adverse drug events over social media channels, we had a
total of 19 vocabularies to start our study as shown in Table 4.1.

Table 4.1: Selected vocabularies from UMLS.
Source Abbreviation
(SAB)
US Edition of SNOMEDCT
SNOMEDCT_US
Consumer Health Vocabulary
CHV
Medical Subject Headings
MSH
Library of Congress Subject Headings, Northwestern University subset
LCH_NW
Logical Observation Identifiers Names and Codes (LOINC)
LNC
RxNorm Vocabulary
RXNORM
U.S. Food and Drug Administration
NCI_FDA
Veterans Health Administration National Drug File
VANDF
Metathesaurus FDA Structured Product Labels
MTHSPL
Foundational Model of Anatomy Ontology
FMA
Medical Dictionary for Regulatory Activities Terminology (MedDRA)
MDR
University of Washington Digital Anatomist
UWDA
WHO Adverse Reaction Terminology
WHO
National Institute of Child Health and Human Development
NCI_NICHD
Common Terminology Criteria for Adverse Events
NCI_CTCAE
National Drug File – FDASPL
NDFRT_FDASPL
International Classification of Diseases, 10th Edition, Clinical Modification
ICD10CM
Metathesaurus HCPCS Hierarchical Terms
MTHHH
Gold Standard Drug Database
GS
Source Name

Refining the VC selection: Now that we have the vocabularies chosen from UMLS, our
next task is to reduce the list to get the best possible vocabularies based on the concepts defined
in each VC, and the coverage of problem domain terms. To filter the vocabularies, we consider
the following five features:
1. Total CUI’s: Total number of concept unique identifiers (CUIs) listed for the vocabulary;
2. Terms Detected: number of problem domain terms detected in the vocabulary;
3. Concept coverage: number of concepts (CUI’s) listed for problem domain terms;
4. Unique concepts: number of unique CUIs listed for each vocabulary; and
5. Clusters Detected: number of clusters which had at least one term detected as CUI.
30

For our purpose, good vocabularies are expected to have higher values for each of these
features.

4.1.3 Similarity Measurement Algorithms (SMAs)
For automated evaluation of semantic similarity, the vocabulary is just one piece of the
puzzle. Another key piece is the specific algorithm to be used to perform the similarity evaluation
using the identified vocabulary. Thus, having narrowed down the vocabulary list as described
above we now turn to the problem of selecting the SMAs. Interestingly, the match performance
can also be influenced by the vocabulary used. Thus, the final choice of vocabulary cannot be
made in isolation, but must consider the specific semantic similarity measurement algorithm
being used. We used all the similarity measurement algorithms listed in UMLS-Similarity program
except the vector measure which is meant to compute semantic relatedness (see Table 4.2). Each
algorithm could have a range different for the similarity values, but for most, the range is from 0
to 1. However, a value of -1 would indicate there is no similarity between the pair of terms based
on the vocabulary configuration. A similarity value could be -1 for two reasons: either one or both
terms in a pair is (are) not found in the given configuration, or there is no path in the configuration
connecting the term pairs.

S. No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16

Table 4.2: Similarity Measurement Algorithms in UMLS-Similarity.
UMLS-Similarity Notation
Type
Reference
lch
path finding
Leacock and Chodorow(1998) [45]
wup
path finding
Wu and Palmer (1994) [20]
zhong
path finding
Zhong et al. (2002) [46]
path
path finding
path measure [18]
upath
path finding
Undirected path [18]
cdist
path finding
Rada et al. (1989) [19]
nam
path finding
Nguyen and Al-Mubaid (2006) [47]
res
IC-based
Resnik (1995) [48]
lin
IC-based
Lin (1988) [49]
jcn
IC-based
Jiang and Conrath (1997) [21]
vector
context vector
Pedersen et al. (2007) [31]
pks
path finding
Pekar and Staab (2002) [50]
faith
IC-based
Pirro and Euzenat (2010) [51]
cmatch
feature-based
Maedche and Staab (2001) [52]
batet
feature-based
Batet et al. (2011) [53]
sanchez
IC-based
Sánchez et al. (2012) [22]
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4.1.4 Joint Selection of VC and SMA
We computed similarity values for the problem domain terms using each combination of
selected VCs and the SMAs. To select the best SMA and VC, we compared their results with those
from human observers. Comparison of the computed similarity values against the human ratings
is performed in two steps: (1) using Pearson correlation against the mean rating from human
observers, and (2) using information retrieval measures.
Correlation Analysis: For the mean representation of human ratings, we calculated the
Pearson correlation coefficient against the corresponding computed similarity values. We used
SciPy package in Python [54] to compute correlations. The syntax for correlation coefficient is
given as:
2

1
2 2

𝑟12 = [∑(𝑌𝑖1 − 𝑌1 ) ∗ (𝑌𝑖2 − 𝑌2 )] / [∑(𝑌𝑖1 − 𝑌1 ) ∗ ∑(𝑌𝑖2 − 𝑌2 ) ]

(2)

Correlation results helped us in reducing the number of combination of vocabulary
configurations and similarity measurement algorithms. The combined results suggested
favorable vocabularies as well as SMAs. We use these results for two key purposes: (1) Filtering
the similarity measurement algorithms given all VCs; and (2) Analyzing the influence of SMAs on
selection of vocabulary configurations.
Information Retrieval Factors: To further evaluate which combination of measurement
algorithms and vocabulary configurations produces computed ratings that best mirror the human
ratings, we grouped the problem domain term pairs into three classes: similar pairs, unknown
pairs, and non-similar pairs. Let S(x,y) be the semantic similarity value between term pair (x, y),
as returned by a given algorithm. We then used two thresholds 𝜏1 and 𝜏2 (𝜏1 ≥ 𝜏2 ) to classify a
word pair (𝑣1 , 𝑣2 ) as follows:
𝑠𝑖𝑚𝑖𝑙𝑎𝑟, 𝑆(𝑣1 , 𝑣2 ) > 𝜏1
𝐶𝑙𝑎𝑠𝑠(𝑆(𝑣1 , 𝑣2 )) = {𝑢𝑛𝑘𝑛𝑜𝑤𝑛, 𝜏1 ≥ 𝑆(𝑣1 , 𝑣2 ) ≥ 𝜏2
𝑛𝑜𝑡 𝑠𝑖𝑚𝑖𝑙𝑎𝑟, 𝑆(𝑣1 , 𝑣2 ) < 𝜏2

(3)

We used traditional information retrieval measures, namely, Precision (Pr), Recall (Rc),
and F-measure (Fm) to evaluate the performance of selected combinations of vocabulary
configurations and similarity measurement algorithms across the three classes. The formula to
compute each of these factors for a given class is given as:
𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 (𝑃𝑟) =

𝑁𝐶 ∩ 𝑁𝐻
𝑁𝐶

(4)
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𝑅𝑒𝑐𝑎𝑙𝑙 (𝑅𝑐) =

𝑁𝐶 ∩ 𝑁𝐻
𝑁𝐻

(5)

where,
NC = Number of computed pairs in a given class
NH = Number of human pairs in a given class
2 ∗ 𝑃𝑟 ∗ 𝑅𝑐
(6)
Pr + 𝑅𝑐
For the final selection of best combination of vocabulary configuration and similarity
measurement algorithm for the given problem domain terms, we combine the information from
the correlation analysis, and from the information retrieval measures.
𝐹 − 𝑚𝑒𝑎𝑠𝑢𝑟𝑒 (𝐹𝑚) =

4.2 Experiments and Results
4.2.1 Filtering Vocabularies
Using programs from the UMLS-Interface [18], we listed the Concept Unique Identifiers
(CUIs) for vocabularies configured with combinations of relations (see Table 4.3). In Table 4.3,
SAB refers to vocabularies and PAR (parent), CHD (child), RB (broader), and RN (narrower) are
the relations defined in UMLS [17]. We observed that most vocabularies contain only PAR, CHD
relations. While some have RB or RN as a primary way of representing hierarchy as seen for
Medical Subject Headings (MSH). Interestingly, some vocabularies have concepts but are not
connected by any relations. Thus, we chose to use relation categories: PAR, CHD; RB, RN;
Similarity relations; and all relations. Similarity relations include all relations except XR (Not
related), Empty relations and DEL (Deleted concept). For the complete list of all relations defined
in UMLS, refer Table B.1 in Appendix B.
Using the UMLS-Interface package, we obtain all the concepts (CUIs) for the problem
domain terms for each vocabulary configuration. Thus, we can evaluate the vocabularies based
on various features discussed in Section 4.1.2. Figures 4.1 – 4.4 show some of the features used
to filter the vocabularies.
Combination with CHV: Based on the results obtained (see Figure 4.1 – 4.4), we observed
that the top 5 vocabularies for anatomy category are SNOMEDCT_US, CHV, LNC, MSH, and FMA.
The top 5 vocabularies for reaction category are SNOMEDCT_US, CHV, MDR, MSH, and LNC.
However, in Table 4.3, we see that CHV has only 2 CUIs for all the various types of relations
specified. Clearly, this doesn’t mean that CHV has only 2 concepts defined in it (see Figure 4.1).
In fact, CHV has no relations defined between CUIs which restricts its use independently. On the
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other hand, we see that there are other vocabularies where we have concepts obtained for
different relation configurations like PAR/CHD, RB/RN, similar relations and all relations.
Interestingly, it is noted that when we provide more number of relations, the UMLS-Similarity
program raises an error and more relations would have a huge computational impact. Thus, we
decided to include significant relations based on the number of concepts retrieved in Table 4.3
as shown in Table 4.4. The sources listed in Table 4.4 were used in combination with CHV as it
has more coverage of terms and improves results as seen in previous work [11], [23], [30].

Table 4.3: Number of concepts in UMLS vocabularies using the SAB/REL configurations.
SAB/REL
CHV
FMA
GS
ICD10CM
LCH_NW
LNC
MDR
MSH
MTHHH
MTHSPL
NCI_CTCAE
NCI_FDA
NCI_NICHD
NDFRT_FDASPL
RxNorm
SNOMEDCT_US
UWDA
VANDF
WHO

PAR, CHD
2
97817
2
91673
2
113526
23439
28575
7142
2
2
2
2
2
2
321004
61087
2
1737

RB, RN
2
2
2
2
2
24157
2
346054
2
2
2
2
2
2
173552
43208
61087
25072
3176

Similar Relationships
2
97830
2
101407
14578
166393
53175
366174
7142
50635
2
2
2
9137
202077
357226
61087
31727
3178

All Relationships
2
97830
2
101407
14578
166393
53175
366174
7142
50635
2
2
2
9137
202077
357997
61087
31727
3178

Table 4.4: Relations used for selected source vocabularies.
Source vocabulary(SAB)
SNOMEDCT_US
MSH
LNC
MDR
FMA

Relations(REL)
PAR/CHD
RB/RN
PAR/CHD
PAR/CHD
PAR/CHD

34

100

Anatomy

Reaction

90

Terms Detected %

80
70
60
50
40
30
20
10
0

Source Vocabularies (SAB)

Figure 4.1: Percentage of terms detected.
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Figure 4.2: Percentage of concepts(CUIs) covered for terms.
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Figure 4.3: Percentage of unique concepts(CUIs) obtained.
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Figure 4.4: Percentage of clusters detected.
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Reaction

4.2.2 Joint Selection of VC and SMA
Correlation Analysis: If the significance level is ≤ 5% (i.e., P-value ≤ 0.05) and the
corresponding correlation coefficient is positively high for any vocabulary configuration and
similarity measurement algorithm, then we say that SMA or VC is favored. From Table 4.5, and
Figures 4.5 and 4.6, we can see that for anatomy category the similarity measurement algorithms
which frequently appear to be good are cmatch, jcn and sanchez with vocabulary configurations
CHV-SNOMEDCT_US and CHV-LNC.
For reaction category, we did not get significant p-value to favor any of the algorithms.
However, it has been observed that nam has very high correlation coefficient with vocabularies
CHV-MDR and CHV-MSH, and undefined value for CHV-LNC. This behavior is because of the
similarity values being -1.0 for most term pairs, resulting in less variability. Overall, the correlation
analysis suggests that CHV-SNOMEDCT_US and CHV-MDR are the best VCs for working on
reaction category terms (see Figure 4.6). Detailed results showing correlation coefficient and pvalue for each SMA and selected VC are given in Appendix B, refer Table B.4 and Table B.5 for
anatomy and reaction categories respectively.

Category
Anatomy
Reaction

Table 4.5: Outcomes of Pearson correlation.
SMA favored
VC favored
cmatch, jcn, sanchez
CHV-SNOMEDCT_US, CHV-LNC
nam
CHV-SNOMEDCT_US, CHV-MDR
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Figure 4.5: Correlation of computed similarity with human ratings – Anatomy pairs.
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Figure 4.6: Correlation of computed similarity with human ratings – Reaction pairs.
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Information Retrieval Factors: For the median of human ratings, we chose thresholds 𝜏1
as 0.75 and 𝜏2 as 0.3 to classify them into similar pairs, unknown pairs, and non-similar pairs.
Similar to human ratings, for the SMA-VC obtained similarity values we chose 𝜏1 ranging from 0.5
to 0.95 and 𝜏2 ranging from 0.05 to 0.45 with a step size of 0.05. We selected the top 5 SMA-VCs
based on F-measure against human rating statistic. For anatomy terms (Table 4.6), we found that
the algorithms jcn, faith, lin, cmatch and sanchez with CHV-SNOMEDCT_US vocabulary are having
high F-measure values with respect to human ratings. For reaction category (Table 4.7), the
algorithms wup, lin, pks, cmatch with CHV-SNOMEDCT_US vocabulary configuration, and res with
CHV-MDR vocabulary configuration performed well. Interestingly, we observe that sanchez has
good F-measure for both CHV-SNOMEDCT_US and CHV-MDR.
Table 4.6 and 4.7 shows results only for similar pairs class. Detailed results for each class
including similar pairs, non-similar pairs, unknown pairs are described in Table B.6 and Table B.7
given in Appendix B for anatomy and reaction categories respectively.

Table 4.6: Top 5 Similarity Algorithm/Vocabulary Configurations (Similar Pairs – Anatomy).
Measure
τ1
τ2
τdiff
Configuration
Pr
Rc
Fm
jcn
0.8
0.5
0.3
CHV-SNOMEDCT_US
0.89
0.62
0.73
faith
0.7
0.5
0.2
CHV-SNOMEDCT_US
0.89
0.62
0.73
lin
0.8
0.45
0.35
CHV-SNOMEDCT_US
0.89
0.62
0.73
cmatch
0.5
0.45
0.05
CHV-SNOMEDCT_US
0.73
0.62
0.67
sanchez
0.8
0.5
0.3
CHV-SNOMEDCT_US
0.73
0.62
0.67

Table 4.7: Top 5 Similarity Algorithm/Vocabulary Configurations (Similar Pairs – Reaction).
Measure
τ1
τ2
τdiff
Configuration
Pr
Rc
Fm
pks
0.55
0.35
0.2
CHV-SNOMEDCT_US
1
0.3
0.46
res
0.8
0.3
0.5
CHV-MDR
1
0.3
0.46
sanchez
0.5
0.4
0.1
CHV-MDR
1
0.3
0.46
wup
0.75
0.3
0.45
CHV-SNOMEDCT_US
1
0.3
0.46
sanchez
0.85
0.3
0.55
CHV-SNOMEDCT_US
0.75
0.3
0.43

4.2.3 Application to Evaluating ADE Surveillance Systems
Considering both the information retrieval factors the correlation analysis, our results
suggest the following: for anatomy term pairs, we should use jcn, cmatch, or sanchez similarity
measurement algorithm with CHV-SNOMEDCT_US vocabulary configuration. For reaction term
pairs, we should use sanchez, res, or wup similarity measurement algorithm, with CHV39

SNOMEDCT_US or CHV-MDR vocabulary configuration. A key observation is the need for a
combination of vocabularies (typically, CHV with some others), rather than one single vocabulary
as has been used in prior work, such as [8]. Prior work also did not consider the impact of the
similarity measurement algorithm on the results. We evaluated suggested ADE narratives from
social media based on the method described in Chapter 3 for non-overlapping windows using the
BBW data discussed in Section 4.1.1. We considered four cases (see Table 4.8): exact match i.e.,
not using semantic similarity; and the other 3 cases with similarity measure algorithm sanchez
along with vocabulary configurations CHV, SNOMEDCT_US and combination of CHVSNOMEDCT_US. Exact match is a string matching technique as used in Adjeroh et al. [8] where
the authors used this methodology to compare the ADE narratives by expanding terms having
similar meanings. The obtained results indicate that using semantic similarity has significantly
greater improvement, especially, our suggested approach using a vocabulary configuration
combining CHV-SNOMEDCT_US outperformed others.

Table 4.8: Evaluating social media ADE narratives for BBW data.
Anatomy
Reaction
Approach
Pr
Rc
Fm
Pr
Rc
exact match
0.048
0.176
0.076
0.022
0.140
CHV
0.048
0.176
0.076
0.024
0.141
SNOMEDCT_US
0.181
0.395
0.249
0.155
0.402
CHV-SNOMEDCT_US
0.197
0.452
0.275
0.175
0.465

Fm
0.038
0.041
0.224
0.255

4.3 Discussion
In our implementation, we chose UMLS-Similarity as it is built on UMLS which provides
access to multiple vocabularies unlike other alternatives which require configuring vocabularies
individually. In addition to this advantage, it has been observed in prior studies that using UMLS
vocabularies would generate good results having higher agreement with human judgements [11],
[23], [30].
The human ratings we used had a good representation of doctors, health professionals,
health science students, engineering graduates and general graduate students. We even
collected responses from Amazon’s Mechanical Turk users having at least a US Bachelor’s Degree
[55]. Overall we achieved an interrater agreement of 80% average correlation for over a hundred
human observer ratings. As the participants were familiar with social media as a significant source
of healthcare information and considering the interrater agreement, we believe our dataset best
fits the testing.
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We followed a-step-by-step approach testing all the vocabulary configurations and
similarity measure algorithms exhaustively, to get the best suitable VC and SMA combination for
the adverse drug event terms. Our results showed that the configuration of CHV-SNOMEDCT_US
is the best for anatomy terms using the IC-based similarity measure algorithms sanchez and jcn.
It is also observed that CHV-MDR and CHV-SNOMEDCT_US configurations work well for reaction
category terms with sanchez similarity measure algorithm. However, our results also indicate
that using biomedical ontologies and the similarity measures is not sufficient for reaction
category terms. The major reason is that reaction terms are more general and are not as specific
when compared to anatomy category terms. Thus, we believe that using general English
vocabularies such as WordNet [56] along with UMLS would improve the semantic similarity for
reaction category terms.
Our findings also show that the vocabulary MedDRA -- Medical Dictionary for Regulatory
Activities (abbreviated as MDR in UMLS) has a good representation of reaction category problem
domain terms. This can be considered in the light of the fact that SIDER, a well-known dataset for
representing side effects uses MedDRA to generate side effect names [57].
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Chapter 5
Conclusion and Future Work
We study the problem of Adverse Drug Events and the postmarketing drug surveillance
involved to detect such harmful events. The study included examining prior works in adverse
drug events (ADE) detection using social media as a prime resource. Primarily our objective was
focused on fusing social media UGC channels for ADE detection, as the signal fusion technique
had seen to be generating promising results in terms of early detection of ADE. During this study
we introduced a novel approach of using graphical causal model for social media signal fusion.
Using the proposed Causality-based technique, we were able to investigate ADE detection on 90
drugs having a total of 107 FDA black box warnings. Further, we presented a methodology to
evaluate precision and recall of detected ADE narratives against the gold standard FDA using
semantic similarity algorithms published in biomedical domain.
We experimented different similarity measure algorithms designed for biomedical
ontologies. We showed that choosing a measure alone is not enough for computing semantic
similarity for terms in a problem domain. Likewise, having known of a vocabulary which is related
to a particular problem domain does not solve the problem of computing semantic similarity for
the terms in that problem domain. We defined a way of choosing the vocabulary first, we also
showed that combining a vocabulary with CHV improves the concept coverage and thereby
covering more terms from the problem domain and later we experimented each configuration
of vocabulary with different measures. The results shown in this work are based on the existing
measures published in UMLS-Similarity program version 1.47 and the source vocabularies
extracted from UMLS version 2017AA. For future releases of UMLS and the UMLS-Similarity
program the methodology we developed can still be used to find the best measure and
vocabulary configuration combination for a given problem domain terms.
Unlike most of the prior studies which focused only on ADE detection or some of them
just representing the recall of detected ADE narrative, we evaluated the detected ADEs in terms
of timeliness, recall and precision. Our results had a good detection rate, precision and recall
considering the dataset we have used representing over 100 FDA black box warnings. In future
we would like to further examine causality on fusing additional social media channels including
search query logs. Identifying the false alarms and detecting ADEs for unknown FDA blackbox
warnings could be some of the prospective studies. Another direction for future work could be
to implement semantic similarity algorithms in capturing signals from social media channels. Also
utilizing general English vocabularies like WordNet [56] in addition to UMLS could be one more
interesting aspect to consider.
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Appendix A
Causality Based Signal Fusion
Table A.1: List of 90 drugs used in Causality Based Signal Fusion.
ABLAVAR
EXJADE
AVELOX
LETAIRIS
RITUXAN
FIORICET
ONTAK
PERFOROMIST
COZAAR
SEREVENT
ACTIQ
MULTAQ
MULTIHANCE
MAGNEVIST
SIMPONI
TEKTURNA
RANEXA
OMNISCAN
CELLCEPT
RAPAMUNE
ALTACE
DEPAKENE
PROHANCE
MYFORTIC
OSMOPREP
ARZERRA
HALCION
OPTIMARK
VIRAMUNE
VISICOL
ATACAND
ADVAIR
EOVIST
NIZORAL
SUTENT
AVANDAMET
OCTAGAM
HUMIRA
ORTHO EVRA
TASIGNA
AVANDIA
ZORTRESS
PRINZIDE
MITOXANTRONE HCL
TASINGA
IMURAN
ELAPRASE
HYZAAR
NOVANTRONE
INCIVEK
REGRANEX
RAPTIVA
IDURSULFASE
ZYPREXA
ANDROGEL
BROVANA
TRUVADA
INCLUSIG
ORTHO NOVUM
FARESTON
SYMBICORT
ENBREL
INFED
ACEON
TYGACIL
ZYBAN
ESTRADERM
SOPRANOX
PROMACTA
TYSABRI
APLENZIN
POTIGA
SPORANOX
PROPYLTHIOURACIL
ULTRACET
CIMZIA
FACTIVE
EPZICOM
QUALAQUIN
PROMETRIUM
CLEOCIN
FLOXIN
TRIZIVIR
REGLAN
STAVZOR
DANTRIUM
FLUDARA
ARAVA
REMICADE
VIREAD
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Appendix B
Evaluation of Semantic Similarity for ADE Narratives
Table B.1: Relationships defined in UMLS.
REL (Relationship)

Description

AQ

Allowed qualifier

CHD

has child relationship in a Metathesaurus source vocabulary

DEL

Deleted concept

PAR

has parent relationship in a Metathesaurus source vocabulary

QB

can be qualified by.

RB

has a broader relationship

RL

the relationship is similar or "alike". the two concepts are similar or
"alike". In the current edition of the Metathesaurus, most relationships
with this attribute are mappings provided by a source, named in SAB and
SL; hence concepts linked by this relationship may be synonymous, i.e.
self-referential: CUI1 = CUI2. In previous releases, some MeSH
Supplementary Concept relationships were represented in this way.

RN

has a narrower relationship

RO

has relationship other than synonymous, narrower, or broader

RQ

related and possibly synonymous.

RU

Related, unspecified

SIB

has sibling relationship in a Metathesaurus source vocabulary.

SY

source asserted synonymy.

XR

Not related, no mapping
Empty relationship

48

Problem Domain Terms used in Evaluation of Semantic Similarity
This appendix lists all the biomedical terms used in this research. It is organized as follows:
1. Clusters - The problem domain terms for this research are represented in terms of
clusters having one or more terms for each cluster. The clusters are organized into:
a. Anatomy Clusters
b. Reaction Clusters
2. Terms – The multiple terms representing each cluster are expanded to get total terms
in each category:
a. Anatomy Terms
b. Reaction Terms

1.a Anatomy Clusters
We have 105 clusters in anatomy category listed as follows:
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.

{abdomen}
{achilles}
{anus, anal}
{appendix}
{arm, arms}
{artery, arteries, arterial}
{back}
{bladder}
{blood}
{bone marrow}
{bone, bones}
{brain}
{breast, breasts, boob, boobs}
{buttocks, butt, ass}
{canal}
{cardiovascular, cardio}
{cervex, cervical}
{cheek, cheeks, cheekbones}
{chest}
{child, children, childrens, children's}
{chin}
{clavical}
{cognitive, cognition}
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24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.

{colon}
{ear, ears, earlobe, earlobes}
{elbow, elbows}
{erectile}
{eye, eyes}
{face}
{female, females}
{foot, feet}
{forearm, forearms}
{forehead}
{gastric}
{genital, genitals}
{gland, glands}
{hair}
{hand, palm}
{head}
{heart, heartbeat}
{heel}
{hip, hips}
{hive, hives}
{immune system}
{impair, impaired}
{infant, infants}
{intestinal, intestine, intestines}
{joint, joints}
{kidney}
{knee, knees}
{leg, legs}
{ligament, ligaments}
{lip, lips}
{liver}
{lobe, lobes}
{lumbar}
{lung, lungs}
{lymph node, lymph nodes, lymph gland, lymph glands}
{lymph}
{macular}
{male, males}
{man, men}
{mental}
{mouth}
{muscle, muscles, muscular}
{nail, nails}
{neck}
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68.
69.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
85.
86.
87.
88.
89.
90.
91.
92.
93.
94.
95.
96.
97.
98.
99.
100.
101.
102.
103.
104.
105.

{nerve, nerves}
{newborn, newborns}
{nipple, nipples}
{nose}
{ovarian, ovary, ovaries}
{pancreas}
{pectoral}
{pelvis}
{peptic}
{plasma cell, plasma cells}
{pregnant, pregnancy}
{pulmonary}
{pulse}
{rectum, rectal}
{respiratory}
{retina, retinal}
{rheumatic}
{shoulder, shoulders}
{sinus}
{skin}
{spine, spinal cord}
{spleen}
{sternum}
{stomach}
{tendon}
{testicle, testicular, testes}
{thigh, thighs}
{thoracic}
{throat}
{tongue}
{tonsil, tonsils}
{tooth, teeth}
{urinary}
{vagina, vaginal}
{vein, venous, veins}
{white blood cell, white blood cells}
{women, woman}
{wrist, wrists}
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1.b Reaction Clusters
We have 202 clusters in reaction category listed as follows:
1.
{abnormality, abnormalities, abnormal}
2.
{ache, aching, aches, ached}
3.
{acne}
4.
{acute}
5.
{addiction, addictive}
6.
{adverse}
7.
{aggression, aggressive}
8.
{agitate, agitated, agitates, agitation}
9.
{akathisia}
10.
{allergic, allergy, allergen}
11.
{amnesia}
12.
{anemia}
13.
{angina}
14.
{anorexia, anorexic}
15.
{anxiety, anxious}
16.
{appendicitis, appendectomy}
17.
{arrhythmia}
18.
{asthenia}
19.
{atrocious}
20.
{attack}
21.
{awful}
22.
{bad}
23.
{benign}
24.
{bleed, bleeding, bleedings, bleeds, blood, bloody}
25.
{blind, blindness}
26.
{blister, blisters}
27.
{blur, blurred, blurry, blurs}
28.
{bradycardia}
29.
{breakdown}
30.
{breath, breathe, breathing}
31.
{burn, burning, burns, burned}
32.
{cancer, cancerous}
33.
{cause, causes, caused}
34.
{chill, chills}
35.
{chronic}
36.
{clot, clots, clotting}
37.
{colitis}
38.
{confusion}
39.
{constipation}
40.
{convulsion, convulsions}
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41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.

{cramp, cramps, cramping}
{crohns disease, crohn syndrome, regional enteritis}
{crystalization, crystal, crystals}
{damage, damaged, damages}
{danger, dangers, dangerous, dangerously}
{deaf, deafness}
{death, dead, died}
{decrease, decreasing, decreased}
{depressed, depression}
{destruction, destroy, destroys, destroyed}
{diabetes, diabetic}
{diarrhea}
{difficult}
{dire}
{disorder}
{diverticulitis}
{diverticulosis}
{dizziness, dizzy}
{drowsiness, drowsy}
{dysfunction}
{dyskinesia}
{dyspepsia}
{dyspnea}
{eczema}
{edema}
{effect, effects}
{epilepsy}
{excess, excessive, overly}
{exhaustion, exhausted, exhausting}
{explode, exploding, explosive, explosion}
{failure, failures}
{faint, fainting}
{fatigue, fatigued, fatiguing, fatigues}
{fetal circulation}
{fever, fevers}
{flush, flushed, flushes, flushing}
{fracture, fractures}
{gas, gaseous, gassy, gastritis}
{hallucinating, hallucinations}
{headache, headaches}
{heartburn}
{hepatitis c, hcv}
{hive, hives}
{horrible, horrific, horrifying}
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85.
86.
87.
88.
89.
90.
91.
92.
93.
94.
95.
96.
97.
98.
99.
100.
101.
102.
103.
104.
105.
106.
107.
108.
109.
110.
111.
112.
113.
114.
115.
116.
117.
118.
119.
120.
121.
122.
123.
124.
125.
126.
127.
128.

{hostile}
{human immunodeficiency virus, hiv, acquired immunodeficiency syndrome, aids}
{hurt, hurts, hurting}
{hyperactive}
{hyperglycemia}
{hyperkalemia}
{hypertension}
{hypoglycemia}
{hypotension}
{ill, illness}
{impair, impaired, impairs, impairing}
{impotence, impotent}
{impulsive}
{inability, unable}
{increase, increased, increasing}
{indigestion}
{infect, infected, infection, infects, infections}
{inflamation, inflamed, inflame}
{injure, injury, injuries, injured}
{insomnia}
{interaction, interactions}
{interval, intervals}
{irreparable}
{irreversible}
{irritable, irritate, irritated, irritability, irritates}
{itch, itching, itchy, itches}
{jaundice}
{ketoacidosis}
{leukemia}
{leukoencephalopathy, leukodystrophy}
{loss, losses}
{lymphoma}
{malignancies, malignancy, malignant}
{melanoma}
{mellitus}
{miscarriage}
{mortified}
{murmur, murmurs}
{myopathy, myopathic}
{nausea, nauseous}
{nervousness}
{neuropathy}
{numb, numbness, numbing}
{obstructive sleep apnea, osa}
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129.
130.
131.
132.
133.
134.
135.
136.
137.
138.
139.
140.
141.
142.
143.
144.
145.
146.
147.
148.
149.
150.
151.
152.
153.
154.
155.
156.
157.
158.
159.
160.
161.
162.
163.
164.
165.
166.
167.
168.
169.
170.
171.
172.

{pain, painful, pains}
{palpitations}
{pancreatitis}
{panicky}
{paresthesia}
{parkinsonism}
{persistent}
{pneumonia}
{pounding}
{pressure}
{priapism}
{problem, problems}
{progressive multifocal leukoencephalopathy, pml}
{psychiatric, psychotic, psychosis, psycho}
{pulmonary arterial hypertension, pah, pulmonary hypertension}
{pulsate, pulsating}
{rapid, rapidly}
{rash, rashes}
{react, reaction, reactions}
{reduce, reducing, reduced, reduction, reductions}
{regulatory, regulation, regulate}
{rhythm, rhythms}
{ringing}
{runny}
{rupture, ruptures, ruptured, rupturing}
{sad, sadness}
{sclerosis}
{seizure, seizures, seizing}
{sensation}
{sensitivity, sensitive}
{serious, seriousness, seriously}
{serotonin syndrome, serotonin toxicity, serotonin sickness, serotonin poisoning}
{severe, severely}
{shakiness, shaky}
{sharp}
{short, shortness, shortening, shorter}
{sleep, sleeping, sleepiness, slept}
{sore, soreness}
{spasm, spasms}
{stroke, strokes}
{stuffy, stuffiness, congest, congested, congestion}
{sudden}
{sugar, glycosylate, glycosylated, hemoglobin, hba1c}
{suicidal, suicide}
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173.
174.
175.
176.
177.
178.
179.
180.
181.
182.
183.
184.
185.
186.
187.
188.
189.
190.
191.
192.
193.
194.
195.
196.
197.
198.
199.
200.
201.
202.

{sweat, sweats, sweating}
{swell, swelling, swollen, swells}
{syncope}
{tachycardia}
{temper, tempers}
{tenderness}
{tendonitis}
{terrible}
{terrified, terrifying}
{thrombosis, thromboembolism}
{tingle, tingling}
{tinnitus}
{tired, tiredness, tire}
{torsades de pointes, ventricular tachycardia}
{toxicity}
{trauma, traumatic}
{tremor, tremors}
{tumor, tumors, tumorous}
{ulcer, ulcers, ulcerative}
{unexplained}
{upset, irritated, irritable, irritate, irritation, upsetting}
{vaginitis}
{vertigo}
{virus, viral}
{vomit, vomits, vomiting, vomited}
{wart, warts}
{watery}
{weak, weaken, weakening, weakness, weaknesses}
{weight}
{worse, worsen, worsening}
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2.a Anatomy Terms
For the 105 anatomy clusters we have 178 anatomy terms as shown in Table B.2.

abdomen
anal
arms
arterial
blood
bones
breasts
buttocks
canal
cervex
cheeks
child
children's
cognitive
ear
earlobes
erectile
face
foot
forearms
genital
glands
palm
heartbeat
hips
immune system
infant
intestine
joints
knees
ligament
lips
lobes
lungs
lymph gland
macular

Table B.2: Anatomy terms.
achilles
appendix
artery
back
bone marrow
brain
boob
butt
cardiovascular
cervical
cheekbones
children
chin
cognition
ears
elbow
eye
female
feet
forehead
genitals
hair
head
heel
hive
impair
infants
intestines
kidney
leg
ligaments
liver
lumbar
lymph node
lymph glands
male
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anus
arm
arteries
bladder
bone
breast
boobs
ass
cardio
cheek
chest
childrens
clavical
colon
earlobe
elbows
eyes
females
forearm
gastric
gland
hand
heart
hip
hives
impaired
intestinal
joint
knee
legs
lip
lobe
lung
lymph nodes
lymph
males

man
mouth
muscular
neck
newborn
nipples
ovary
pectoral
plasma cell
pregnancy
rectum
retina
shoulder
skin
spleen
tendon
testes
thoracic
tonsil
teeth
vaginal
veins
women
wrists

men
muscle
nail
nerve
newborns
nose
ovaries
pelvis
plasma cells
pulmonary
rectal
retinal
shoulders
spine
sternum
testicle
thigh
throat
tonsils
urinary
vein
white blood cell
woman
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mental
muscles
nails
nerves
nipple
ovarian
pancreas
peptic
pregnant
pulse
respiratory
rheumatic
sinus
spinal cord
stomach
testicular
thighs
tongue
tooth
vagina
venous
white blood cells
wrist

2.b Reaction Terms
For the 202 reaction clusters we have 417 reaction terms as shown in Table B.3.

abnormality
ache
ached
addiction
aggression
agitated
akathisia
allergen
angina
anxiety
appendectomy
atrocious
bad
bleeding
blood
blindness
blur
blurs
breath
burn
burned
cause
chill
clot
colitis
convulsion
cramps
crohn syndrome
crystal
damaged
dangers
deaf
dead
decreasing
depression
destroys

Table B.3: Reaction terms.
abnormalities
aching
acne
addictive
aggressive
agitates
allergic
amnesia
anorexia
anxious
arrhythmia
attack
benign
bleedings
bloody
blister
blurred
bradycardia
breathe
burning
cancer
causes
chills
clots
confusion
convulsions
cramping
regional enteritis
crystals
damages
dangerous
deafness
died
decreased
destruction
destroyed
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abnormal
aches
acute
adverse
agitate
agitation
allergy
anemia
anorexic
appendicitis
asthenia
awful
bleed
bleeds
blind
blisters
blurry
breakdown
breathing
burns
cancerous
caused
chronic
clotting
constipation
cramp
crohns disease
crystalization
damage
danger
dangerously
death
decrease
depressed
destroy
diabetes

diabetic
dire
diverticulosis
drowsiness
dyskinesia
eczema
effects
excessive
exhausted
exploding
failure
fainting
fatiguing
fever
flushed
fracture
gaseous
hallucinating
headaches
hcv
horrible
hostile
acquired
immunodeficiency
syndrome
hurts
hyperglycemia
hypoglycemia
illness
impairs
impotent
unable
increasing
infected
infections
inflame
injuries
interaction
intervals
irritable
irritability
itching

diarrhea
disorder
dizziness
drowsy
dyspepsia
edema
epilepsy
overly
exhausting
explosive
failures
fatigue
fatigues
fevers
flushes
fractures
gassy
hallucinations
heartburn
hive
horrific
human immunodeficiency virus

difficult
diverticulitis
dizzy
dysfunction
dyspnea
effect
excess
exhaustion
explode
explosion
faint
fatigued
fetal circulation
flush
flushing
gas
gastritis
headache
hepatitis c
hives
horrifying
hiv

aids

hurt

hurting
hyperkalemia
hypotension
impair
impairing
impulsive
increase
indigestion
infection
inflamation
injure
injured
interactions
irreparable
irritate
irritates
itchy

hyperactive
hypertension
ill
impaired
impotence
inability
increased
infect
infects
inflamed
injury
insomnia
interval
irreversible
irritated
itch
itches
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jaundice
leukoencephalopathy
losses
malignancy
mellitus
murmur
myopathic
nervousness
numbness
osa
pains
panicky
persistent
pressure
problems
psychiatric
psycho
pulmonary hypertension
rapid
rashes
reactions
reduced
regulatory
rhythm
runny
ruptured
sadness
seizures
sensitivity
seriousness
serotonin toxicity
severe
shaky
shortness
sleep
slept
spasm
strokes
congest
sudden

ketoacidosis
leukodystrophy
lymphoma
malignant
miscarriage
murmurs
nausea
neuropathy
numbing
pain
palpitations
paresthesia
pneumonia
priapism
progressive multifocal
leukoencephalopathy
psychotic
pulmonary arterial
hypertension
pulsate
rapidly
react
reduce
reduction
regulation
rhythms
rupture
rupturing
sclerosis
seizing
sensitive
seriously
serotonin sickness
severely
sharp
shortening
sleeping
sore
spasms
stuffy
congested
sugar
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leukemia
loss
malignancies
melanoma
mortified
myopathy
nauseous
numb
obstructive sleep apnea
painful
pancreatitis
parkinsonism
pounding
problem
pml
psychosis
pah
pulsating
rash
reaction
reducing
reductions
regulate
ringing
ruptures
sad
seizure
sensation
serious
serotonin syndrome
serotonin poisoning
shakiness
short
shorter
sleepiness
soreness
stroke
stuffiness
congestion
glycosylate

glycosylated
suicidal
sweats
swelling
syncope
tempers
terrible
thrombosis
tingling
tiredness
ventricular tachycardia
traumatic
tumor
ulcer
unexplained
irritable
upsetting
virus
vomits
wart
weak
weakness
worse

hemoglobin
suicide
sweating
swollen
tachycardia
tenderness
terrified
thromboembolism
tinnitus
tire
toxicity
tremor
tumors
ulcers
upset
irritate
vaginitis
viral
vomiting
warts
weaken
weaknesses
worsen
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hba1c
sweat
swell
swells
temper
tendonitis
terrifying
tingle
tired
torsades de pointes
trauma
tremors
tumorous
ulcerative
irritated
irritation
vertigo
vomit
vomited
watery
weakening
weight
worsening

Correlation of Computed Similarity against Human Ratings
Table B.4: Anatomy – Pearson correlation results.
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Table B.5: Reaction – Pearson correlation results.
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Information Retrieval Factors
Table B.6: Anatomy – Top 20 SMAs/VCs. (Ranked by Fm_similar)
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Table B.7: Reaction – Top 20 SMAs/VCs. (Ranked by Fm_similar)
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